Company tests mobile health for tuberculosis treatment

Post Date: 
NIH: News and Events

With the support of an NIMHD Small Business Innovation Research grant, Seiguer's team [at emocha Mobile Health] collaborated with researchers at the Johns Hopkins University Center for Clinical Global Health Education to test adherence to a daily medication regimen. Twenty-eight patients using miDOT participated at public health clinics in Baltimore and elsewhere in Maryland. The research team is testing whether miDOT can be as effective as DOT and at what cost.

“Our preliminary data show we can secure 93 percent medication adherence using video observation and can save more than $1,000 per TB patient over 6 months with software costs included,” said Seiguer.